Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections-A Cohort Study.

Cai, Yiying; Leck, Hui; Tan, Ray W; Teo, Jocelyn Q; Lim, Tze-Peng; Lee, Winnie; Chlebicki, Maciej Piotr; Kwa, Andrea L

Cai, Yiying; Leck, Hui; Tan, Ray W; Teo, Jocelyn Q; Lim, Tze-Peng; Lee, Winnie; Chlebicki, Maciej Piotr; Kwa, Andrea L.

Afiliación

Cai Y; Department of Pharmacy, Singapore General Hospital, Singapore 169608, Singapore.
Leck H; Department of Pharmacy, National University of Singapore, Singapore 117559, Singapore.
Tan RW; Department of Pharmacy, Singapore General Hospital, Singapore 169608, Singapore.
Teo JQ; Department of Pharmacy, National University of Singapore, Singapore 117559, Singapore.
Lim TP; Department of Pharmacy, Singapore General Hospital, Singapore 169608, Singapore.
Lee W; Saw Swee Hock School of Public Health, National University of Singapore and National University Health Systems, Singapore 117549, Singapore.
Chlebicki MP; Department of Pharmacy, Singapore General Hospital, Singapore 169608, Singapore.
Kwa AL; Academic Clinical Programme (Pathology), SingHealth Duke-NUS, Singapore 169857, Singapore.

Antibiotics (Basel) ; 9(8)2020 Jul 27.

Article en En | MEDLINE | ID: mdl-32726974

Palabras clave

pharmacodynamics; pharmacokinetics; polymyxin B nephrotoxicity; polymyxins

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Antibiotics (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Singapur

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google